Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Chemistry and Laboratory Medicine

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1515/cclm-2013-0578PMID 24108211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The activation of HMGB1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE/JNK/NF-κB pathway

  2013cited by this paper
• Glycosaminoglycans are functional ligands for receptor for advanced glycation end‐products in tumors

  2013influential reference
• RAGE Genetic Polymorphisms Are Associated with Risk, Chemotherapy Response and Prognosis in Patients with Advanced NSCLC

  2012influential reference
• HMGB1 is a therapeutic target for leukemia.

  2012cited by this paper
• Role of advanced glycation end products in cardiovascular disease.

  2012cited by this paper
• A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

  2012cited by this paper
• Embryonic overexpression of receptors for advanced glycation end-products by alveolar epithelium induces an imbalance between proliferation and apoptosis.

  2012cited by this paper
• Analysis of the expression of the Notch3 receptor protein in adult lung cancer

  2012cited by this paper
• Interaction of receptor for advanced glycation end products with advanced oxidation protein products induces podocyte injury.

  2012cited by this paper
• Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes.

  2012cited by this paper
• Receptor for Advanced Glycation End Products (RAGE) Functions as Receptor for Specific Sulfated Glycosaminoglycans, and Anti-RAGE Antibody or Sulfated Glycosaminoglycans Delivered in Vivo Inhibit Pulmonary Metastasis of Tumor Cells*

  2012influential reference
• Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?

  2011cited by this paper
• Prognostic Potential and Tumor Growth-Inhibiting Effect of Plasma Advanced Glycation End Products in Non-Small Cell Lung Carcinoma

  2011cited by this paper
• Heparan Sulfate Is Essential for High Mobility Group Protein 1 (HMGB1) Signaling by the Receptor for Advanced Glycation End Products (RAGE)*

  2011influential reference
• Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

  2011cited by this paper
• Advanced glycation end product recognition by the receptor for AGEs.

  2011cited by this paper
• RAGE: a single receptor fits multiple ligands.

  2011cited by this paper
• Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis.

  2010cited by this paper
• Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma

  2010cited by this paper
• Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function

  2010cited by this paper
• Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer.

  2010influential reference
• Integrin signaling and lung cancer

  2010cited by this paper
• The Receptor for Advanced Glycation End Products (RAGE) and the Lung

  2010cited by this paper
• The 1.5 Å Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand Binding*

  2010cited by this paper
• RAGE and the pathogenesis of chronic kidney disease

  2010cited by this paper
• Heparan sulfate in lung morphogenesis: The elephant in the room.

  2010cited by this paper
• The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

  2010cited by this paper
• High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.

  2010cited by this paper
• Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.

  2010cited by this paper
• Advanced glycation endproducts: from precursors to RAGE: round and round we go

  2010cited by this paper
• Chylothorax: aetiology, diagnosis and therapeutic options.

  2010cited by this paper
• Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer.

  2009cited by this paper
• Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions.

  2009cited by this paper
• Lung cancer A549 cells migrate directionally in DC electric fields with polarized and activated EGFRs

  2009cited by this paper
• RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation

  2009influential reference
• Electrical fields in wound healing-An overriding signal that directs cell migration.

  2009cited by this paper
• Cell Communication and Signaling BioMed Central Review The receptor RAGE: Bridging inflammation and cancer

  2009cited by this paper
• Heparin: an intervenor in cell communication

  2009cited by this paper
• Soluble forms of RAGE in human diseases: clinical and therapeutical implications.

  2009cited by this paper
• Interactions between heparan sulfate and proteins-design and functional implications.

  2009cited by this paper
• Increased expression of Toll-like receptors 4 and 9 in human lung cancer

  2009cited by this paper
• Electrical dimensions in cell science

  2009cited by this paper
• Alterations of the Notch pathway in lung cancer

  2009cited by this paper
• The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer.

  2009cited by this paper
• Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation

  2009cited by this paper
• Electromagnetic effects - From cell biology to medicine.

  2009cited by this paper
• Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth

  2008cited by this paper
• Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42*

  2008cited by this paper
• Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.

  2008cited by this paper
• Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types.

  2008cited by this paper
• Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix.

  2008cited by this paper
• Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)*

  2008cited by this paper
• Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)

  2008cited by this paper
• Microbial subversion of heparan sulfate proteoglycans.

  2008cited by this paper
• Advanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2'-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry.

  2008cited by this paper
• Maturing Dendritic Cells Depend on RAGE for In Vivo Homing to Lymph Nodes1

  2008cited by this paper
• Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

  2008cited by this paper
• RAGE signaling sustains inflammation and promotes tumor development

  2008cited by this paper
• RAGE Ligation Affects T Cell Activation and Controls T Cell Differentiation1

  2008cited by this paper
• Endogenous secretory receptor for advanced glycation end products in non-small cell lung carcinoma.

  2007influential reference
• Glycosaminoglycans and Proteoglycans: Overlooked Entities?

  2007cited by this paper
• Heparan sulfate-protein interactions – A concept for drug design?

  2007cited by this paper
• Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.

  2007cited by this paper
• Masquerader: High Mobility Group Box-1 and Cancer

  2007cited by this paper
• EGF receptor signalling is essential for electric-field-directed migration of breast cancer cells

  2007cited by this paper
• RAGE and RAGE ligands in cancer.

  2007cited by this paper
• Fibroblasts mediate induction of high mobility group box protein 1 in lung epithelial cancer cells by diffusible factors.

  2007cited by this paper
• Hypochlorite‐modified albumin colocalizes with RAGE in the artery wall and promotes MCP‐1 expression via the RAGE‐Erk1/2 MAP‐kinase pathway

  2007cited by this paper
• Bmc Developmental Biology Developmental Expression of the Receptor for Advanced Glycation End-products (rage) and Its Response to Hyperoxia in the Neonatal Rat Lung

  2007cited by this paper
• Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma.

  2007cited by this paper
• S100A8 and S100A9 in inflammation and cancer.

  2006cited by this paper
• Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature.

  2006cited by this paper
• Interactions between heparan sulfate and proteins: the concept of specificity

  2006cited by this paper
• Poor outcome of patients with pulmonary adenocarcinoma showing decreased E-cadherin combined with increased S100A4 expression.

  2006cited by this paper
• Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells

  2006influential reference
• Proliferative stimulus of lung fibroblasts on lung cancer cells is impaired by the receptor for advanced glycation end-products.

  2006influential reference
• Developmental signalling pathways in lung cancer

  2006cited by this paper
• The Amphoterin (HMGB1)/Receptor for Advanced Glycation End Products (RAGE) Pair Modulates Myoblast Proliferation, Apoptosis, Adhesiveness, Migration, and Invasiveness

  2006cited by this paper
• Wnt signalling in lung development and diseases

  2006cited by this paper
• Matrix proteoglycans as effector molecules for epithelial cell function

  2005cited by this paper
• Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products1

  2005cited by this paper
• Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.

  2005cited by this paper
• Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer

  2005cited by this paper
• Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development

  2005cited by this paper
• The pathobiology of diabetic complications: a unifying mechanism.

  2005cited by this paper
• Understanding RAGE, the receptor for advanced glycation end products

  2005cited by this paper
• Receptor for Advanced Glycation End Products and Its Ligands: A Journey from the Complications of Diabetes to Its Pathogenesis

  2005cited by this paper
• S100 Family Members and Trypsinogens Are Predictors of Distant Metastasis and Survival in Early-Stage Non-Small Cell Lung Cancer

  2004cited by this paper
• Discrimination of human lung neoplasm from normal lung by two target genes.

  2004cited by this paper
• Receptor for advanced glycation end‐products is a marker of type I lung alveolar cells

  2004cited by this paper
• Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma.

  2004influential reference
• S100P Stimulates Cell Proliferation and Survival via Receptor for Activated Glycation End Products (RAGE)*

  2004cited by this paper
• Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions.

  2004cited by this paper
• RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.

  2003cited by this paper
• Alveolar type I cells: molecular phenotype and development.

  2003cited by this paper
• Endogenous electric fields in embryos during development, regeneration and wound healing.

  2003cited by this paper
• Left/right, up/down: The role of endogenous electrical fields as directional signals in development, repair and invasion

  2003cited by this paper
• Endogenous electric fields in embryos during development, regeneration and wound healing.

  2003cited by this paper
• Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing?

  2003cited by this paper
• The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins

  2003cited by this paper

• Circulating proteins associated with histological subtypes of lung cancer from genetic and population-based perspectives

  2025cites this paper
• Intravenous Multifunctional Nanotherapy for Treating Dry Age‐Related Macular Degeneration

  2025cites this paper
• Gene Expression Analysis and Validation of a Novel Biomarker Signature for Early-Stage Lung Adenocarcinoma

  2025influential citation
• Immune dysregulation of diabetes in tuberculosis.

  2025cites this paper
• The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases

  2024cites this paper
• Vil-Cre specific Slfn3KO mice exhibit sex-specific differences in lung, stomach, cecum, kidney, and proximal colon differentiation markers and Slfn family members expression levels

  2023cites this paper
• The Ratio of RAGE Isoforms Is Affected by HMGB1 and Its Truncated Form Only in A549 but not in H1299 Lung Cancer Cell Lines

  2022cites this paper
• Intracellular Protein S-Nitrosylation—A Cells Response to Extracellular S100B and RAGE Receptor

  2022cites this paper
• Receptor for Advanced Glycation End Products (RAGE) and Its Polymorphic Variants as Predictive Diagnostic and Prognostic Markers of NSCLCs: a Perspective

  2021cites this paper
• A network pharmacology approach for investigating the multi-target mechanisms of Huangqi in the treatment of colorectal cancer

  2021cites this paper
• RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer

  2020cites this paper
• Advanced Glycation End Products (AGEs), Protein Aggregation and their Crosstalk: New Insight in Tumorigenesis.

  2019cites this paper
• The Potential of Receptor for Advanced Glycation End Products (RAGE) as a Therapeutic Target for Lung Associated Diseases.

  2019cites this paper
• Impact of RAGE polymorphisms on urothelial cell carcinoma clinicopathologic characteristics and long-term survival.

  2019cites this paper
• Plasma sRAGE Acts as Genetically Regulated Causal Intermediate in Sepsis-Associated ARDS.

  2019cites this paper
• Clinical/Translational Aspects of Advanced Glycation End-Products.

  2019cites this paper
• Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer

  2019cites this paper
• Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome : Plasma sRAGE as a Causal Intermediate in ARDS Risk

  2019cites this paper
• Stress oxydant et glycoxydation : impact des produits avancés de glycation sur les mitochondries des cellules endothéliales dans le cadre de la pathologie diabétique

  2018cites this paper
• RAGE in Cancer Lung: the End of a Long and Winding Road is in Sight

  2018cites this paper
• An investigation into the therapeutic effect of flavonoid chrysin on RAGE expression in response to INF-γ in differentiated THP-1 cells in vitro.

  2018cites this paper
• Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients.

  2017cites this paper
• The shedding-derived soluble receptor for advanced glycation endproducts sustains inflammation during acute Pseudomonas aeruginosa lung infection.

  2017cites this paper
• Carboxymethyllysine, an Advanced Glycation End-Product, Promotes the Invasion and Migration of Lung Cancer A549 Cells

  2017cites this paper
• Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 2: Underlying Biologic Mechanisms.

  2017cites this paper
• Glycation & the RAGE axis: targeting signal transduction through DIAPH1

  2017cites this paper
• Potential of glycative stress targeting for cancer prevention.

  2017cites this paper
• The Mouse-Specific Splice Variant mRAGE_v4 Encodes a Membrane-Bound RAGE That Is Resistant to Shedding and Does Not Contribute to the Production of Soluble RAGE

  2016cites this paper
• Méthodes destinées à développer des plans de traitements médicamenteux personnalisés et développement de médicaments ciblés basés sur des profils protéomiques

  2016cites this paper
• The diagnostic utility and tendency of the soluble receptor for advanced glycation end products (sRAGE) in exudative pleural effusion.

  2016cites this paper
• The multiple faces of RAGE – opportunities for therapeutic intervention in aging and chronic disease

  2016cites this paper
• Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis

  2016cites this paper
• Advanced Glycation End-Products Enhance Lung Cancer Cell Invasion and Migration

  2016cites this paper
• Role of receptor for advanced glycation end products in the complication and progression of various types of cancers.

  2015cites this paper
• RAGE and its ligands in cancer - culprits, biomarkers, or therapeutic targets?

  2015cites this paper
• Prevention of Protein Glycation by Natural Compounds

  2015cites this paper
• Multiple criteria optimization joint analyses of microarray experiments in lung cancer: from existing microarray data to new knowledge

  2015cites this paper
• Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases.

  2014influential citation
• In silico assessment of S100A12 monomer and dimer structural dynamics: implications for the understanding of its metal-induced conformational changes

  2014cites this paper
• Ischemia-reperfusion injury of the retina is linked to necroptosis via the ERK1/2-RIP3 pathway

  2014cites this paper
• IMARS HIGHLIGHTS Research Commentaries for the Members of The International Maillard Reaction Society

  2013cites this paper